Concepedia

Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer

Sridhar Mani, John W. Kugler, James A. Knost, David F. Sciortino, Joseph Gibbons, Juan Carlos García‐Ruiz, Rafat Ansari, Richard L. Schilsky, Everett E. Vokes

Investigational New Drugs · 1998 · 33 citations · 9 references

DOI

Concepts

References

9

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

, , +16

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

Gemcitabine: metabolism, mechanisms of action, and self-potentiation.

William Plunkett, Peng Huang, Yi-Zheng Xu et al. · PubMed · 1995 · 756 citations

, , +6

Surgery for Recurrent Colon Cancer: Strategies for Identifying Resectable Recurrence and Success Rates after Resection

Richard M. Goldberg · Annals of Internal Medicine · 1998 · 268 citations

, , +17

Saturation of 2?, 2?-difluorodeoxycytidine 5?-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine

Ralf Grunewald, James L. Abbruzzese, Peter G. Tarassoff et al. · Cancer Chemotherapy and Pharmacology · 1991 · 250 citations

, , +4